MXPA02004741A - Formulacion liquida de heparina. - Google Patents

Formulacion liquida de heparina.

Info

Publication number
MXPA02004741A
MXPA02004741A MXPA02004741A MXPA02004741A MXPA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A
Authority
MX
Mexico
Prior art keywords
heparin formulation
liquid heparin
liquid
formulation
heparin
Prior art date
Application number
MXPA02004741A
Other languages
English (en)
Spanish (es)
Inventor
Agarwal Rajesh
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of MXPA02004741A publication Critical patent/MXPA02004741A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
MXPA02004741A 1999-11-12 2000-11-10 Formulacion liquida de heparina. MXPA02004741A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16520999P 1999-11-12 1999-11-12
PCT/US2000/030890 WO2001034114A1 (en) 1999-11-12 2000-11-10 Liquid heparin formulation

Publications (1)

Publication Number Publication Date
MXPA02004741A true MXPA02004741A (es) 2003-12-11

Family

ID=22597926

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004741A MXPA02004741A (es) 1999-11-12 2000-11-10 Formulacion liquida de heparina.

Country Status (4)

Country Link
AU (1) AU1594801A (de)
DE (1) DE20022960U1 (de)
MX (1) MXPA02004741A (de)
WO (1) WO2001034114A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
ITMI20012599A1 (it) 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
US8039018B2 (en) 2004-05-06 2011-10-18 Emisphere Technologies, Inc. Solid dosage form of wetted heparin
CA2565188C (en) 2004-05-14 2014-03-04 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CA2566747C (en) 2004-05-19 2015-04-28 Emisphere Technologies, Inc. Topical cromolyn formulations
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
EP1773376A4 (de) 2004-08-03 2009-07-01 Emisphere Tech Inc Antidiabetische orale insulinbiguanidkombination
EP1830831B1 (de) 2004-12-29 2015-01-21 Emisphere Technologies, Inc. Pharmazeutische formulierungen von galliumsalzen
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
EP1792621B1 (de) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Oral verabreichbare Heparinderivate
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2007133944A2 (en) 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
WO2008003050A2 (en) 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
EP2134351B1 (de) 2007-03-13 2016-04-27 Nutrition 21, Inc. Verfahren und zusammensetzungen zur verzögerten freisetzung von chrom
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
JP5985985B2 (ja) 2009-08-03 2016-09-06 エミスフィアー テクノロジーズ インコーポレイテッドＥｍｉｓｐｈｅｒｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ． 胃腸への影響が減少した即効型ナプロキセン組成物
EP2680861B1 (de) 2011-03-01 2022-05-04 Nutrition 21, LLC Zusammensetzungen enthaltend insulin und chrom zur behandlung und vorbeugung von diabetes und hypoglykämie und verwandten krankheiten
WO2017127025A1 (en) * 2016-01-19 2017-07-27 Namz Pte. Ltd. A cosmetic composition and the use thereof for regulating skin quality
MX2018009748A (es) 2016-02-11 2019-02-07 Nutrition 21 Llc Composiciones que contienen cromo para mejorar la salud y el estado físico.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2001034114A1 (en) 2001-05-17
DE20022960U1 (de) 2002-07-25
AU1594801A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
AP2006003492A0 (en) Azaindoles.
ZA200200477B (en) 2-pyrazolin-5-ones.
MXPA02004741A (es) Formulacion liquida de heparina.
ZA200002892B (en) Rapidly absorbed liquid compositions.
ZA200003312B (en) Display units.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
ZA200201829B (en) New phenylpiperazines.
ZA200000233B (en) Liquid dispensing pump.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
HK1029502A1 (en) Slider-pull-assembling unit.
ZA200208656B (en) Liquid formulations.
HK1032222A1 (en) Liquid container.
HK1034298A1 (en) Scaffolding.
GB9817354D0 (en) Liquid formulation
MXPA01012681A (es) Recipiente.
ZA200110454B (en) Pharmaceutical complex.
GB0029720D0 (en) I.S machine7544232001
AU3977500A (en) Liquid cleaning arrangement
HK1042406A1 (en) Liquid formulation.
HUP0103393A3 (en) Liquid pump
ZA994697B (en) Pharmaceutical formulation.
ZA200204581B (en) Nitro-sulfobenzamides.
ZA200007511B (en) Liquid meter.